Kaffe Bueno, a leading Danish bioscience company renowned for its innovative approach in valorising coffee by-products, announced an investment deal led by Borregaard with the participation of the European Innovation Council Fund (EIC Fund), Dalgaard Group, EIFO, PINC and The Yield Lab.
The financial injection, totalling €6.2 million, marks a pivotal moment in Kaffe Bueno’s growth trajectory and validates the investors’ belief in the company’s vision and technology. Borregaard, a global leader in biomass refining and advanced environmentally friendly biochemicals, has shown an interest in Kaffe Bueno’s unique approach to coffee biorefining and increased market demand for high-performing biobased solutions.
“Kaffe Bueno’s approach to upcycling of coffee by-products into high-value products for global niche markets aligns well with Borregaard’s business model. We are impressed by what they have achieved so far and look forward to being part of their ongoing journey. We realise that it will take time to scale up and fine tune production and to establish a global business, but we see this as an interesting opportunity with potential synergies between the two companies in several functions”, says Per A. Sørlie, President and CEO of Borregaard.
“It is amazing to receive the support of such a strong partner and leader in the refining of biomass”, says Juan Pablo Medina, CEO of Kaffe Bueno. “This investment is a clear testament of support for our efficient biorefinery technology and all the different novel applications/products we have developed from coffee side streams. With Borregaard’s expertise in biorefinery operations and access to key markets and customers, our path to a commercial size biorefinery is clearer than ever.”